BPC-157 + TB-500
Product Name: BPC-157 + TB-500
Brand: LAWLESS LABS
Form: Lyophilized Peptide Powder (Freeze-Dried)
Content per Vial:
BPC-157: 5 mg
TB-500: 5 mg
Total Peptide Content: 10 mg per vial
Package Size: 1 Vial
Storage: Refrigerated (2–8°C)
Description
BPC-157 and TB-500 are experimental synthetic peptides commonly studied together in preclinical research due to their potential complementary roles in tissue repair and recovery. BPC-157 is primarily investigated for its effects on tendon, ligament, muscle, gastrointestinal, and soft tissue healing, while TB-500 (a synthetic peptide based on the active region of thymosin beta-4) is studied for its potential to support cell migration, angiogenesis, and tissue regeneration.
The combination is intended for research purposes only and is not approved as a medication for human therapeutic use.
Potential Research Benefits
May support tendon and ligament repair.
May promote muscle recovery following injury.
May assist soft tissue healing.
May support wound healing in experimental models.
May promote angiogenesis (formation of new blood vessels).
May help reduce inflammation associated with tissue injury in preclinical studies.
May support recovery from musculoskeletal damage.
Typical Research Dosage
Research protocols vary widely depending on study design.
Common experimental ranges include:
BPC-157: 200–500 mcg per day.
TB-500: 2–5 mg per week, often divided into multiple administrations.
Dosage, route of administration, and treatment duration should be determined solely by the specific research protocol.
Reconstitution
The lyophilized peptide is typically reconstituted with bacteriostatic water under sterile laboratory conditions before research use. The final concentration depends on the volume of diluent added.
Storage
Before reconstitution:
Store refrigerated at 2–8°C.
Protect from light.
Do not freeze unless specified by the manufacturer.
After reconstitution:
Keep refrigerated at 2–8°C.
Use within the stability period appropriate for the chosen diluent and research protocol.
Avoid repeated freeze–thaw cycles.
Warnings
For research use only.
Not approved for human therapeutic or veterinary use by major regulatory authorities.
Safety, efficacy, and long-term effects have not been established in humans.
Should only be handled using appropriate laboratory techniques.
Keep out of reach of children.
Summary
BPC-157 + TB-500 by LAWLESS LABS contains 5 mg of BPC-157 and 5 mg of TB-500 in a single refrigerated lyophilized vial (10 mg total peptide content). This experimental peptide combination is widely investigated for its potential roles in tissue repair, musculoskeletal recovery, angiogenesis, and wound healing, but it remains a research compound and is not approved for therapeutic use.
| Brands | LAWLESS LABS |